Physician Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Physician Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$288K	Sell	644 -68	-10%	-$31.7K	0.04%	153
2025 Q4	$323K	Buy	712 +14	+2%	+$6.03K	0.04%	135
2025 Q3	$273K	Buy	698 +157	+29%	+$65.6K	0.04%	152
2025 Q2	$241K	Buy	541 +3	+0.6%	+$1.38K	0.04%	159
2025 Q1	$261K	Buy	538 +40	+8%	+$18.6K	0.04%	149
2024 Q4	$201K	Sell	498 -32	-6%	-$14.8K	0.03%	182
2024 Q3	$257K	Sell	530 -27	-5%	-$13K	0.05%	154
2024 Q2	$272K	Buy	+557	New	+$242K	0.05%	136
2022 Q1	–	Sell	-929	Closed	-$206K	–	169
2021 Q4	$206K	Buy	+929	New	+$181K	0.05%	155
2021 Q2	–	Sell	-967	Closed	-$208K	–	156
2021 Q1	$208K	Buy	+967	New	+$212K	0.07%	137

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Physician Wealth Advisors's VRTX Position: Q1 2026 in Review

Physician Wealth Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 9.6% in Q1 2026, selling an estimated $31.7K and leaving 644 shares worth $288K. The position accounts for 0.04% of the portfolio, ranked #153.

Physician Wealth Advisors first reported a position in VRTX in Q1 2021 and has held it in 10 quarters since. The position peaked at $323K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Physician Wealth Advisors held 644 shares of Vertex Pharmaceuticals worth $288K as of Q1 2026.
Physician Wealth Advisors sold 68 Vertex Pharmaceuticals shares in Q1 2026, an estimated $31.7K.
Vertex Pharmaceuticals made up 0.04% of Physician Wealth Advisors's portfolio in Q1 2026, its #153 holding.
Physician Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
Physician Wealth Advisors's Vertex Pharmaceuticals position peaked at $323K in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.